News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Achaogen (AKAO) To Present At 13th Annual Needham Healthcare Conference


4/7/2014 9:08:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections, announced today that it will present at the 13th Annual Needham Healthcare Conference in New York, New York. Kenneth Hillan, Chief Executive Officer, and Derek Bertocci, Chief Financial Officer, are scheduled to present on Tuesday, April 8 at 10:40 a.m. ET, at the Westin NY Grand Central Hotel.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
Achaogen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES